MedTrace Logo

Cognitive Training Using Feuerstein Instrumental Enrichment

NCT02774083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2019-09-24

No results posted yet for this study

Summary

Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on a Mediated Learning Experience. The program takes into consideration the unique characteristics and requirements of the older population. The program is composed of a variety of cognitive tasks that offer systematic activities intended to stimulate mental and cognitive development.

Objective: To examine the influence of the Feuerstein Program on the cognitive function and well-being of participants suffering from Mild Cognitive Impairment (MCI).

Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being of the participants.

Methods: Residents of retirement homes will be offered to participate in the research. Participants will undergo cognitive and functional assessments that will be carried out on four specific dates. The participants of the Intervention Group will participate in the Feuerstein program using a method of mediated learning while the Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.

Conditions

Interventions

BEHAVIORAL

Feuerstein Program

Mediated learning cognitive enhancement program

BEHAVIORAL

Adler Program

Social and emotional group program

Sponsors & Collaborators

  • Adolf und Mary Mil-Stiftung

    collaborator OTHER

  • Helen Bader Foundation

    collaborator UNKNOWN

  • Montreal Jewish Community Fund

    collaborator UNKNOWN

  • Rochlin Family Foundation

    collaborator UNKNOWN

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Tzvi Dwolatzky, MD MBBCh · Rambam Health Care Campus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-03
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02774083 on ClinicalTrials.gov